GlassScriptPhysician profile
Allan M Smiley
NPI 1649264862
$1,539.23
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $739 · 2020: $800.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $884.39 | 2019-2020 | |
| Amgen INC. | $109.55 | 2019 | |
| Novartis Pharmaceuticals Corporation | $102.09 | 2019 | |
| Pfizer INC. | $83.70 | 2019 | |
| Janssen Scientific Affairs, LLC | $79.91 | 2019 | |
| Pacira Therapeutics, INC. | $41.85 | 2019 | |
| Celgene Corporation | $41.81 | 2019 | |
| Abbvie INC. | $34.40 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $26.83 | 2019 | |
| Therapeuticsmd, INC. | $23.31 | 2019 | |
| Genzyme Corporation | $18.36 | 2019 | |
| Genentech USA, INC. | $17.83 | 2019 | |
| Ucb, INC. | $16.84 | 2019 | |
| Fidia Pharma USA INC. | $16.25 | 2019 | |
| Lilly USA, LLC | $15.81 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hospira, INC. | $15.43 | 2019 | |
| Nevro Corp. | $10.87 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Allan Smiley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.